Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles

Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator gene (CFTR) that result in diminished quantity and/or function of the CFTR anion channel. F508del-CFTR, the most common CF-causing mutation (found in ∼90% of patients), causes severe processing and trafficking...

Full description

Bibliographic Details
Main Authors: Jennifer L. Taylor-Cousar, Marcus A. Mall, Bonnie W. Ramsey, Edward F. McKone, Elizabeth Tullis, Gautham Marigowda, Charlotte M. McKee, David Waltz, Samuel M. Moskowitz, Jessica Savage, Fengjuan Xuan, Steven M. Rowe
Format: Article
Language:English
Published: European Respiratory Society 2019-06-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/5/2/00082-2019.full

Internet

http://openres.ersjournals.com/content/5/2/00082-2019.full

Similar Items